Key result
Women exhibit ~20% higher Lp(a) levels than men in a nationwide Brazilian cohort.
Why the study?
Lipoprotein(a) is an independent cardiovascular risk factor increasingly used in risk prediction, but its epidemiology in Brazil remains unknown.
What is the distribution of Lipoprotein(a) levels and its association with clinical characteristics in a large Brazilian population?
Cross-Sectional (n=115,197)
Yes
What is the distribution of Lipoprotein(a) levels and its association with clinical characteristics in a large Brazilian population?
Answers are grounded in this paper and cite their sources.
In a large Brazilian cohort, Lp(a) levels were highly skewed, with 18% having levels >50 mg/dL and women displaying significantly higher levels than men.
Lipoprotein(a) (Lp(a)) is an independent risk factor for atherosclerotic disease and is increasingly being incorporated into clinical algorithms of cardiovascular risk prediction. However, the epidemiology of Lp(a) in Brazil remains unknown. The objective of this study was to describe the distribution of Lp(a) levels and its association with laboratory parameters and clinical characteristics in a population of subjects submitted to blood tests in a private laboratory. Methods involved assessing Lp(a) levels from 115,197 subjects in a nationwide database from one Brazilian private laboratory, with Lp(a) measured using a nephelometric assay and expressed in mg/dL. Results showed that among the 115,197 subjects, the median age was 44 years. Women composed 61% of the sample and displayed higher Lp(a) levels in comparison to men (13.90 vs 11.58 mg/dL, p < 0.001). The distribution of Lp(a) levels was skewed rightward, as 70% of the individuals showed levels < 30 mg/dL, and 18% had levels higher than 50 mg/dL. The presence of criteria for diabetes, metabolic syndrome, and levels of HDL-cholesterol and triglycerides showed no correlation with Lp(a) levels. Additionally, there was no significant association between Lp(a) levels in individuals with and without criteria for diabetes and metabolic syndrome. In conclusion, this study represents the largest descriptive analysis of Lp (a) in Brazil, encompassing individuals with a wide age range and geographical distribution. This data contributes to the generation of high-quality evidence needed for improving cardiovascular risk assessment in clinical care settings.
No takes yet. Share an insight, caveat, or question.
Castelo et al. (2025) conducted a cross-sectional in Subjects submitted to blood tests (n=115,197). In a nationwide Brazilian sample, women displayed higher Lipoprotein(a) levels compared to men, with 18% of the total population having levels >/dL.
Synapse has enriched 10 related papers. Consider them for comparative context: